TINGLI HUANG
-
Contact
-
Shanghai
Unit 603, 605, 606, Level 6, 8 Century Avenue, HSBC Building, Pudong New Area Shanghai 200120 China
Shenzhen45/F, China Resources Tower, No.2666 Keyuan South Road, Yuehai Street, Nanshan District, Shenzhen
Tingli Huang is a senior associate of the RuiMin team. Her primary practice areas include M&A, private equity, overseas capital markets and general corporate advice.
Before joining RuiMin, Tingli was an associate of the leading Chinese firm Fangda Partners and with there for 5 years.
Tingli speaks fluent English and Mandarin.
-
Experience
Advising AstraZeneca on its US$1.2bn acquisition of Nasdaq-listed Gracell Biotechnology (ALB China 2024 M&A Deal of the Year Award)
Advising ABB Asea Brown Boveri Ltd. on its acquisition of the wiring and accessories business of Siemens in China
Advising Li & Fung Limited on its post-sale restructuring and buy-back of international freight management business from A.P. Moller-Maersk Group
Advising Alibaba Group, Ant Group, Ali Health, Cainiao, on their investments in target companies covering a wide range of industry sectors including TMT, transportation, entertainment, advertising&media, healthcare, and logistics
Advising large domestic and multinational enterprises such as Olympus, Heytea, and Sino-agriculture Co., and renowned investment institutions such as Welkin Capital, PAG Investment, Westfall and Warburg Pincus on their M&A, private equity and asset transactions covering a wide range of industry sectors including retails, technology manufacturing, TMT, credit and financial services etc.
Advising Midea on its establishment of four joint ventures in China with KUKA AG with a transaction size of RMB4bn
-
Qualifications
Tingli graduated from China University of Political Science & Law where she obtained LLB and LLM degrees. She also obtained an LLM degree from Hamburg University. She is qualified in China.